商务合作
动脉网APP
可切换为仅中文
AbstractThe platelet/high-density lipoprotein ratio (PHR) has been identified as a significant indicator of inflammation and a hypercoagulable state, demonstrating a strong link with the severity of nonalcoholic fatty liver disease (NAFLD) and metabolic syndrome (MetS). However, its correlation with hyperuricemia has not yet been documented.
摘要血小板/高密度脂蛋白比(PHR)已被确定为炎症和高凝状态的重要指标,与非酒精性脂肪性肝病(NAFLD)和代谢综合征(MetS)的严重程度密切相关。然而,它与高尿酸血症的相关性尚未被记录。
This study utilized a cross-sectional design, analyzing data collected from the National Health and Nutrition Examination Survey (NHANES) between 2007 and 2016 in the United States. The platelet/high-density lipoprotein ratio (PHR) was determined by dividing the number of platelets (PLT) by the level of high-density lipoprotein cholesterol (HDL-C).
本研究采用横断面设计,分析了2007年至2016年美国国家健康与营养调查(NHANES)收集的数据。通过将血小板(PLT)的数量除以高密度脂蛋白胆固醇(HDL-C)的水平来确定血小板/高密度脂蛋白比(PHR)。
We employed multivariable logistic regression analyses, generalized additive models, and subgroup analyses to investigate the correlation between PHR and hyperuricemia. The study revealed a hyperuricemia prevalence of 18.56%. Analysis indicated a significant positive correlation between PHR and the risk of hyperuricemia (OR 1.11, 95% CI 1.08, 1.14).
我们采用多变量逻辑回归分析,广义加性模型和亚组分析来研究PHR与高尿酸血症之间的相关性。该研究显示高尿酸血症患病率为18.56%。分析表明,PHR与高尿酸血症风险之间存在显着的正相关(OR 1.11,95%CI 1.08,1.14)。
This correlation remained consistent across different subgroups including age, ethnicity, gender, and body mass index (BMI). Smooth curve fitting demonstrated a saturation effect between PHR and the risk of hyperuricemia. PHR is positively correlated with hyperuricemia and may serve as a novel biomarker for predicting the onset of this condition.
这种相关性在不同的亚组中保持一致,包括年龄,种族,性别和体重指数(BMI)。平滑曲线拟合显示PHR与高尿酸血症风险之间存在饱和效应。PHR与高尿酸血症呈正相关,可作为预测这种疾病发作的新型生物标志物。
Additionally, targeted interventions to improve PHR might help reduce the incidence of hyperuricemia..
此外,有针对性的干预措施以改善PHR可能有助于降低高尿酸血症的发生率。。
IntroductionSerum uric acid (SUA) represents the final product of purine breakdown in humans. Initially, purine is metabolized to hypoxanthine, which is then oxidized by xanthine dehydrogenase (XDH) to xanthine before further oxidation to uric acid (UA)1. Elevated levels of SUA can induce endothelial dysfunction, affecting vascular tone, thrombosis, inflammation, and oxidative stress2.
引言血清尿酸(SUA)代表人类嘌呤分解的最终产物。最初,嘌呤被代谢成次黄嘌呤,然后被黄嘌呤脱氢酶(XDH)氧化成黄嘌呤,然后进一步氧化成尿酸(UA)1。SUA水平升高可诱导内皮功能障碍,影响血管张力,血栓形成,炎症和氧化应激2。
High SUA levels can trigger gout and play a significant role in the development of cardiovascular diseases, including hypertension, atrial fibrillation, heart failure, and coronary artery disease. They are also closely associated with diabetes and metabolic syndrome (MetS)3,4,5,6,7,8. Despite a lack of extensive clinical study evidence, UA-lowering treatments have shown clinical significance in managing chronic kidney disease, blood sugar control, and cardiovascular outcomes9,10,11.
高SUA水平可引发痛风,并在心血管疾病的发展中发挥重要作用,包括高血压,心房颤动,心力衰竭和冠状动脉疾病。它们也与糖尿病和代谢综合征(MetS)3,4,5,6,7,8密切相关。尽管缺乏广泛的临床研究证据,但降尿酸治疗在管理慢性肾脏疾病,血糖控制和心血管结局方面显示出临床意义9,10,11。
In the United States, during 2015–2016, 47.1 million adults met the criteria for hyperuricemia, with a prevalence rate of 20.1%12. This condition and its associated comorbidities significantly increase the public health burden, highlighting the importance of early prediction, identification, and treatment of hyperuricemia.Hyperuricemia is closely associated with coagulation abnormalities.
在美国,2015-2016年期间,4710万成年人符合高尿酸血症的标准,患病率为20.1%12。这种情况及其相关的合并症显着增加了公共卫生负担,突出了高尿酸血症早期预测,鉴定和治疗的重要性。高尿酸血症与凝血异常密切相关。
SUA, through reactive oxygen species (ROS)-mediated oxidative stress, induces an inflammatory state and vascular damage, triggering thrombosis13. Platelets (PLT) serve a crucial function in the coagulation process, and several studies have demonstrated an independent correlation between PLT counts and the width of the PLT distribution representing the activation of PLT and with SUA14,15,16,17.
SUA通过活性氧(ROS)介导的氧化应激诱导炎症状态和血管损伤,引发血栓形成13。血小板(PLT)在凝血过程中起着至关重要的作用,一些研究表明PLT计数与代表PLT活化的PLT分布宽度和SUA14,15,16,17之间存在独立的相关性。
The lipid profile associated with hyperuricemia typically features reduced concentrations of high-density lipoprotein cholesterol (HDL.
与高尿酸血症相关的血脂特征通常是高密度脂蛋白胆固醇(HDL)浓度降低。
Data availability
数据可用性
This data can be found here: https://www.cdc.gov/nchs/nhanes.
这些数据可以在这里找到:https://www.cdc.gov/nchs/nhanes.
ReferencesKimura, Y., Tsukui, D. & Kono, H. Uric acid in inflammation and the pathogenesis of atherosclerosis. Int. J. Mol. Sci. 22(22), 12394 (2021).Article
参考文献Kimura,Y.,Tsukui,D。&Kono,H。尿酸在炎症和动脉粥样硬化的发病机制中。Int.J.Mol.Sci。22(22),12394(2021)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Maruhashi, T., Hisatome, I., Kihara, Y. & Higashi, Y. Hyperuricemia and endothelial function: From molecular background to clinical perspectives. Atherosclerosis 278, 226–231 (2018).Article
Maruhashi,T.,Hisatome,I.,Kihara,Y。&Higashi,Y。高尿酸血症和内皮功能:从分子背景到临床观点。动脉粥样硬化278226-231(2018)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Verdecchia, P. et al. Relation between serum uric acid and risk of cardiovascular disease in essential hypertension: The PIUMA study. Hypertension 36(6), 1072–1078 (2000).Article
Verdecchia,P。等。原发性高血压患者血尿酸与心血管疾病风险的关系:PIUMA研究。高血压36(6),1072-1078(2000)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Kojima, S. et al. Prognostic usefulness of serum uric acid after acute myocardial infarction (the Japanese Acute Coronary Syndrome Study). Am. J. Cardiol. 96(4), 489–495 (2005).Article
Kojima,S.等。急性心肌梗死后血清尿酸的预后有用性(日本急性冠状动脉综合征研究)。美国心脏病杂志。96(4),489-495(2005)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Anker, S. D. et al. Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional, and hemodynamic staging. Circulation 107(15), 1991–1997 (2003).Article
Anker,S.D.等人,《尿酸与慢性心力衰竭的生存:代谢、功能和血液动力学分期的验证和应用》。发行量107(15),1991–1997(2003)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Kawasoe, S. et al. Uric acid level and prevalence of atrial fibrillation in a Japanese general population of 285,882. Circ. J. 80(12), 2453–2459 (2016).Article
Kawasoe,S.等人。285882名日本普通人群的尿酸水平和心房颤动患病率。保监会。J、 80(12),2453-2459(2016)。文章
PubMed
PubMed
Google Scholar
谷歌学者
van der Schaft, N., Brahimaj, A., Wen, K.-X., Franco, O. H. & Dehghan, A. The association between serum uric acid and the incidence of prediabetes and type 2 diabetes mellitus: The Rotterdam Study. PLoS ONE 12(6), e0179482 (2017).Article
van der Schaft,N.,Brahimaj,A.,Wen,K.-X.,Franco,O.H。&Dehghan,A.血清尿酸与糖尿病前期和2型糖尿病发病率之间的关系:鹿特丹研究。PLoS ONE 12(6),e0179482(2017)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Choi, H. K., Ford, E. S., Li, C. & Curhan, G. Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey. Arthritis Care Res. 57(1), 109–115 (2007).Article
Choi,H.K.,Ford,E.S.,Li,C。&Curhan,G。痛风患者代谢综合征的患病率:第三次全国健康和营养检查调查。关节炎护理第57(1),109-115(2007)号决议。文章
Google Scholar
谷歌学者
Kanbay, M. et al. Effect of uric acid-lowering agents on cardiovascular outcome in patients with heart failure: A systematic review and meta-analysis of clinical studies. Angiology 71(4), 315–323 (2020).Article
Kanbay,M.等。降尿酸药物对心力衰竭患者心血管结局的影响:临床研究的系统评价和荟萃分析。血管学71(4),315-323(2020)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Chen, J. et al. Effects of uric acid-lowering treatment on glycemia: A systematic review and meta-analysis. Front. Endocrinol. 11, 577 (2020).Article
Chen,J.等。降尿酸治疗对血糖的影响:系统评价和荟萃分析。正面。内分泌。11577(2020)。文章
Google Scholar
谷歌学者
Tsukamoto, S. et al. Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: A systematic review and network meta-analysis. Clin. Rheumatol. 41, 911–919 (2022).Article
Tsukamoto,S.等人。慢性肾脏病患者使用降尿酸疗法预防肾功能下降:系统评价和网络荟萃分析。临床。风湿病。41911–919(2022)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Chen-Xu, M. Contemporary prevalence of Gout and Hyperuricemia in the United States (National Health and Nutrition Examination Survey [NHANES] 2015–2016) and decadal trends (NHANES 2007–2016). 2018 ACR/ARHP Annual Meeting (ACR, 2018).Țăpoi, L., Șalaru, D. L., Sascău, R. & Stătescu, C.
Chen Xu,M。当代美国痛风和高尿酸血症的患病率(国家健康和营养调查[NHANES]2015-2016)和十年趋势(NHANES 2007-2016)。2018年ACR/ARHP年会(ACR,2018年)。Țăpoi,L.,Șalaru,D.L.,Sascău,R.&Stătescu,C。
Uric acid: An emergent risk marker for thrombosis?. J. Clin. Med. 10(10), 2062 (2021).Article .
尿酸:血栓形成的紧急风险标志物?。J、 临床。医学杂志10(10),2062(2021)。文章。
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Kubota, Y., McAdams-DeMarco, M. & Folsom, A. R. Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. Thromb. Res. 144, 144–148 (2016).Article
Kubota,Y.,McAdams-DeMarco,M。&Folsom,A.R。血清尿酸,痛风和静脉血栓栓塞:社区动脉粥样硬化风险研究。血栓。第144144-148号决议(2016年)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Bluhm, G. B. & Riddle, J. M. (eds) Platelets and Vascular Disease in Gout. Seminars in Arthritis and Rheumatism (Elsevier, 1973).
Bluhm,G.B。和Riddle,J.M。(编辑)痛风中的血小板和血管疾病。关节炎和风湿病研讨会(Elsevier,1973)。
Google Scholar
谷歌学者
Tayefi, M. et al. Relationship between platelet count and platelet width distribution and serum uric acid concentrations in patients with untreated essential hypertension. BioFactors 44(6), 532–538 (2018).Article
Tayefi,M.等人。未经治疗的原发性高血压患者血小板计数与血小板宽度分布和血清尿酸浓度之间的关系。生物因子44(6),532-538(2018)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Liu, X. et al. Association between platelet distribution width and serum uric acid in Chinese population. BioFactors 45(3), 326–334 (2019).Article
Liu,X。等。中国人群血小板分布宽度与血尿酸的关系。生物因子45(3),326-334(2019)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Liang, J. et al. The comparison of dyslipidemia and serum uric acid in patients with gout and asymptomatic hyperuricemia: A cross-sectional study. Lipids Health Dis. 19, 1–7 (2020).Article
Liang,J.等人。痛风和无症状高尿酸血症患者血脂异常和血尿酸的比较:横断面研究。脂质健康疾病。19,1-7(2020)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Jialal, I., Jialal, G. & Adams-Huet, B. The platelet to high density lipoprotein-cholesterol ratio is a valid biomarker of nascent metabolic syndrome. Diabetes/Metab. Res. Rev. 37(6), e3403 (2021).Article
Jialal,I.,Jialal,G。&Adams-Huet,B。血小板与高密度脂蛋白胆固醇的比率是新生代谢综合征的有效生物标志物。糖尿病/代谢。第37(6)号决议,e3403(2021年)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Lu, C.-f et al. Association between the platelet/high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease: Results from NHANES 2017–2020. Lipids Health Dis. 22(1), 130 (2023).Article
Lu,C.-f等人。血小板/高密度脂蛋白胆固醇比率与非酒精性脂肪性肝病之间的关联:NHANES 2017-2020的结果。脂质健康疾病。22(1),130(2023)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Zhang, H., Xu, Y. & Xu, Y. The association of the platelet/high-density lipoprotein cholesterol ratio with self-reported stroke and cardiovascular mortality: A population-based observational study. Lipids Health Dis. 23(1), 121 (2024).Article
Zhang,H.,Xu,Y。&Xu,Y。血小板/高密度脂蛋白胆固醇比率与自我报告的中风和心血管死亡率的关系:一项基于人群的观察性研究。脂质健康疾病。23(1),121(2024)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Ni, J., Lv, L., Wu, P. & Xu, C. Associations between the platelet/high-density lipoprotein cholesterol ratio and likelihood of nephrolithiasis: A cross-sectional analysis in United States adults. Front. Endocrinol. 15, 1289553 (2024).Article
Ni,J.,Lv,L.,Wu,P。&Xu,C。血小板/高密度脂蛋白胆固醇比率与肾结石可能性之间的关联:美国成年人的横断面分析。正面。内分泌。151289553(2024)。文章
Google Scholar
谷歌学者
Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150(9), 604–612 (2009).Article
Levey,A.S.等人提出了一个新的估算肾小球滤过率的公式。安,实习生。医学杂志150(9),604-612(2009)。文章
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Nagahama, K. et al. Hyperuricemia predicts future metabolic syndrome: A 4-year follow-up study of a large screened cohort in Okinawa, Japan. Hypertens. Res. 37(3), 232–238 (2014).Article
Nagahama,K.等人,《高尿酸血症预测未来的代谢综合征:日本冲绳一项大型筛查队列的4年随访研究》。高血压。第37(3)号决议,第232-238(2014)号决议。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Tu, Y.-C., Liu, Y.-H., Chen, S.-C. & Su, H.-M. Metabolic syndrome and its components are associated with new-onset hyperuricemia in a large taiwanese population follow-up study. Nutrients 15(5), 1083 (2023).Article
Tu,Y.-C.,Liu,Y.-H.,Chen,S.-C.&Su,H.-M。在一项大型台湾人群随访研究中,代谢综合征及其成分与新发高尿酸血症有关。营养素15(5),1083(2023)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Tomiyama, H. et al. Relationships among hyperuricemia, metabolic syndrome, and endothelial function. Am. J. Hypertens. 24(7), 770–774 (2011).Article
Tomiyama,H。等人。高尿酸血症、代谢综合征和内皮功能之间的关系。Am.J.Hypertens。24(7),770-774(2011)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Frutuoso, J. & Bourbon, M. Cholesterol levels and glomerular filtration rate–Is there any association?. Atherosclerosis 252, e150 (2016).Article
Frutouso,J。和Bourbon,M。胆固醇水平和肾小球滤过率-有任何关联吗?。动脉粥样硬化252,e150(2016)。文章
Google Scholar
谷歌学者
Wasada, T., Katsumori, K., Saeki, A. & Iwatani, M. Hyperuricemia and insulin resistance. Nihon Rinsho Jpn. J. Clin. Med. 54(12), 3293–3296 (1996).CAS
Wasada,T.,Katsumori,K.,Saeki,A。&Iwatani,M。高尿酸血症和胰岛素抵抗。Nihon Rinsho日本。J、 临床。医学杂志54(12),3293-3296(1996)。中科院
Google Scholar
谷歌学者
Yang, T. et al. Association between high-sensitivity C-reactive protein and hyperuricemia. Rheumatol. Int. 36, 561–6 (2016).Article
Yang,T。等人。高敏C反应蛋白与高尿酸血症之间的关系。风湿病。Int.36561–6(2016)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Chen, M.-Q., Wang, H.-Y., Shi, W.-R. & Sun, Y.-X. Estimate of prevalent hyperuricemia by systemic inflammation response index: Results from a rural Chinese population. Postgrad. Med. 133(2), 242–249 (2021).Article
Chen,M.-Q.,Wang,H.-Y.,Shi,W.-R.&Sun,Y.-X.通过全身炎症反应指数估计高尿酸血症的流行:来自中国农村人口的结果。研究生。医学133(2),242-249(2021)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Chen, M.-Q., Shi, W.-R., Shi, C.-N., Zhou, Y.-P. & Sun, Y.-X. Impact of monocyte to high-density lipoprotein ratio on prevalent hyperuricemia: Findings from a rural Chinese population. Lipids Health Dis. 19(1), 1–9 (2020).Article
Chen,M.-Q.,Shi,W.-R.,Shi,C.-N.,Zhou,Y.-P.&Sun,Y.-X.单核细胞与高密度脂蛋白比率对高尿酸血症流行的影响:来自中国农村人群的发现。脂质健康疾病。19(1),1-9(2020)。文章
CAS
中科院
Google Scholar
谷歌学者
Wang, L. et al. The correlation between dietary inflammatory index and risk of hyperuricemia in the US population. Medicine 102(20), e33374 (2023).Article
Wang,L.等人。饮食炎症指数与美国人群高尿酸血症风险之间的相关性。医学102(20),e33374(2023)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Xie, F. et al. Association between systemic immune-inflammation index and serum uric acid in US adolescents: A population-based study. Nutr. Metab. Cardiovasc. Dis. 34(1), 206–213 (2024).Article
谢,F。等。美国青少年全身免疫炎症指数与血尿酸之间的关系:一项基于人群的研究。营养。代谢。心血管。Dis。34(1),206-213(2024)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Li, Y., Liu, X. & Luo, Y. Monocyte to high-density lipoprotein cholesterol ratio and serum uric acid in Chinese adults: A cross-sectional study. BMC Endocr. Disord. 22(1), 48 (2022).Article
Li,Y.,Liu,X。&Luo,Y。中国成年人单核细胞与高密度脂蛋白胆固醇比率和血清尿酸:一项横断面研究。BMC内分泌。混乱。22(1),48(2022)。文章
CAS
中科院
PubMed
PubMed
PubMed Central
公共医学中心
Google Scholar
谷歌学者
Murphy, A. J. & Woollard, K. J. High-density lipoprotein: A potent inhibitor of inflammation. Clin. Exp. Pharmacol. Physiol. 37(7), 710–718 (2010).Article
Murphy,A.J。和Woollard,K.J。高密度脂蛋白:一种有效的炎症抑制剂。临床。药理学实验。生理学。37(7),710-718(2010)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Murphy, A., Chin-Dusting, J., Sviridov, D. & Woollard, K. J. The anti inflammatory effects of high density lipoproteins. Curr. Med. Chem. 16(6), 667–675 (2009).Article
Murphy,A.,Chin Dusting,J.,Sviridov,D。和Woollard,K.J。高密度脂蛋白的抗炎作用。货币。医学化学。16(6),667-675(2009)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Murphy, A. J. et al. High-density lipoprotein reduces the human monocyte inflammatory response. Arterioscler. Thromb. Vasc. Biol. 28(11), 2071–2077 (2008).Article
Murphy,A.J。等人。高密度脂蛋白降低人单核细胞炎症反应。动脉硬化。血栓。Vasc。生物学杂志28(11),2071-2077(2008)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Jung, S. W., Kim, S.-M., Kim, Y. G., Lee, S.-H. & Moon, J.-Y. Uric acid and inflammation in kidney disease. Am. J. Physiol. 318, 1327–1340 (2020).
Jung,S.W.,Kim,S.-M.,Kim,Y.G.,Lee,S.-H.和Moon,J.-Y.尿酸与肾脏疾病炎症。J.生理学318, 1327-1340 (2020).
Google Scholar
谷歌学者
De Lucchi, L. et al. Serum uric acid levels and the risk of recurrent venous thromboembolism. J. Thromb. Haemostas. 19(1), 194–201 (2021).Article
De Lucchi,L。等人。血清尿酸水平和复发性静脉血栓栓塞的风险。J、 血栓。止血药。19(1),194-201(2021)。文章
Google Scholar
谷歌学者
Kanellis, J. et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 41(6), 1287–1293 (2003).Article
Kanellis,J。等人。尿酸通过丝裂原活化蛋白激酶和环氧合酶-2刺激血管平滑肌细胞中单核细胞趋化蛋白-1的产生。高血压41(6),1287-1293(2003)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Spiga, R. et al. Uric acid is associated with inflammatory biomarkers and induces inflammation via activating the NF-κB signaling pathway in HepG2 cells. Arterioscler. Thromb. Vasc. Biol. 37(6), 1241–1249 (2017).Article
Spiga,R。等人。尿酸与炎症生物标志物相关,并通过激活HepG2细胞中的NF-κB信号通路诱导炎症。动脉硬化。血栓。Vasc。生物学37(6),1241-1249(2017)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Nieto, F. J., Iribarren, C., Gross, M. D., Comstock, G. W. & Cutler, R. G. Uric acid and serum antioxidant capacity: A reaction to atherosclerosis?. Atherosclerosis 148(1), 131–139 (2000).Article
Nieto,F.J.,Iribarren,C.,Gross,M.D.,Comstock,G.W。&Cutler,R.G。尿酸和血清抗氧化能力:对动脉粥样硬化的反应?。动脉粥样硬化148(1),131-139(2000)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Shimizu, Y. et al. Serum uric acid level increases in proportion to the severity of pulmonary thromboembolism. Circ. J. 66(6), 571–575 (2002).Article
Shimizu,Y。等人。血清尿酸水平与肺血栓栓塞的严重程度成比例增加。保监会。J、 66(6),571-575(2002)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Tang, R.-B. et al. Serum uric acid and risk of left atrial thrombus in patients with nonvalvular atrial fibrillation. Can. J. Cardiol. 30(11), 1415–1421 (2014).Article
Tang,R.-B.等。非瓣膜性心房颤动患者的血清尿酸和左心房血栓风险。可以。J、 心脏病。30(11),1415–1421(2014)。文章
PubMed
PubMed
Google Scholar
谷歌学者
Yu, H. et al. Hyperuricemia enhances procoagulant activity of vascular endothelial cells through TMEM16F regulated phosphatidylserine exposure and microparticle release. FASEB J. 35(9), e21808 (2021).Article
Yu,H。等人。高尿酸血症通过TMEM16F调节的磷脂酰丝氨酸暴露和微粒释放增强血管内皮细胞的促凝血活性。FASEB J.35(9),e21808(2021)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Cheng, X. et al. Prothrombotic effects of high uric acid in mice via activation of MEF2C-dependent NF-κB pathway by upregulating let-7c. Aging (Albany NY) 12(18), 17976 (2020).Article
Cheng,X。等人。高尿酸通过上调let-7c激活MEF2C依赖性NF-κB途径对小鼠的促血栓形成作用。老龄化(纽约州奥尔巴尼)12(18),17976(2020)。文章
CAS
中科院
PubMed
PubMed
Google Scholar
谷歌学者
Download referencesAuthor informationAuthors and AffiliationsDepartment of Cardio Surgery Intensive Care Unit, Ningbo Medical Centre Li Huili Hospital, Ningbo, ChinaLaisha Yan, Xiaoyan Hu, Shanshan Wu & Shunying ZhaoAuthorsLaisha YanView author publicationsYou can also search for this author in.
下载参考文献作者信息作者和附属机构宁波医学中心心外科重症监护室李惠利医院,宁波,中国莱沙燕,胡晓燕,吴珊珊和赵顺英作者出版物莱沙燕查看作者出版物您也可以在中搜索该作者。
PubMed Google ScholarXiaoyan HuView author publicationsYou can also search for this author in
PubMed Google ScholarXiaoyan HuView作者出版物您也可以在
PubMed Google ScholarShanshan WuView author publicationsYou can also search for this author in
PubMed Google Scholarshan WuView作者出版物您也可以在
PubMed Google ScholarShunying ZhaoView author publicationsYou can also search for this author in
PubMed Google ScholarShunying ZhaoView作者出版物您也可以在
PubMed Google ScholarContributionsSYZ was involved in the study design. XYH, LSY and SSW were involved in data analysis and graph preparation. LSY was responsible for writing and revising the manuscript. All authors reviewed the manuscript.Corresponding authorCorrespondence to.
PubMed Google ScholarContributionsSYZ参与了研究设计。XYH,LSY和SSW参与了数据分析和图形准备。LSY负责撰写和修改手稿。所有作者都审阅了手稿。对应作者对应。
Shunying Zhao.Ethics declarations
赵顺英。道德宣言
Competing interests
相互竞争的利益
The authors declare no competing interests.
作者声明没有利益冲突。
Additional informationPublisher's noteSpringer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.Rights and permissions
Additional informationPublisher的noteSpringer Nature在已发布地图和机构隶属关系中的管辖权主张方面保持中立。权限和权限
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
开放获取本文是根据知识共享署名4.0国际许可证授权的,该许可证允许以任何媒体或格式使用,共享,改编,分发和复制,只要您对原始作者和来源给予适当的信任,提供知识共享许可证的链接,并指出是否进行了更改。
The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
本文中的图像或其他第三方材料包含在文章的知识共享许可中,除非在材料的信用额度中另有说明。如果材料未包含在文章的知识共享许可中,并且您的预期用途不受法律法规的许可或超出许可用途,则您需要直接获得版权所有者的许可。
To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/..
要查看此许可证的副本,请访问http://creativecommons.org/licenses/by/4.0/..
Reprints and permissionsAbout this articleCite this articleYan, L., Hu, X., Wu, S. et al. Association of platelet to high-density lipoprotein cholesterol ratio with hyperuricemia.
转载和许可本文引用本文Yan,L.,Hu,X.,Wu,S。等人。血小板与高密度脂蛋白胆固醇比率与高尿酸血症的关系。
Sci Rep 14, 15641 (2024). https://doi.org/10.1038/s41598-024-66747-xDownload citationReceived: 21 March 2024Accepted: 03 July 2024Published: 08 July 2024DOI: https://doi.org/10.1038/s41598-024-66747-xShare this articleAnyone you share the following link with will be able to read this content:Get shareable linkSorry, a shareable link is not currently available for this article.Copy to clipboard.
Sci Rep 1415641(2024)。https://doi.org/10.1038/s41598-024-66747-xDownload引文收到日期:2024年3月21日接受日期:2024年7月3日发布日期:2024年7月8日OI:https://doi.org/10.1038/s41598-024-66747-xShare本文与您共享以下链接的任何人都可以阅读此内容:获取可共享链接对不起,本文目前没有可共享的链接。复制到剪贴板。
Provided by the Springer Nature SharedIt content-sharing initiative
由Springer Nature SharedIt内容共享计划提供
KeywordsPlateletCholesterolUric acidNHANES
关键词植物甾醇酸
CommentsBy submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
评论通过提交评论,您同意遵守我们的条款和社区指南。如果您发现有虐待行为或不符合我们的条款或准则,请将其标记为不合适。